Pacira BioSciences, Inc. — Director's Dealing 2012

Jun 7, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pacira Pharmaceuticals, Inc. (PCRX)
CIK: 0001396814
Period of Report: 2012-06-05

Reporting Person: Pratt John (General Manager, San Diego)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-06-05	Common Stock	$10.81	A	150000	Acquired	2022-06-04	Common Stock (150000)	Direct

Footnotes

F1: The option vests and becomes exercisable as to 25% of the option shares on June 5, 2013 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months.